Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method
Authors:
- 24 September 2019
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 50 (5) , 545-551
Abstract
1. Hydroxysafflor yellow A (HSYA) is the most pharmaceutically relevant compound in Xuebijing (XBJ) for traumatic brain injury (TBI) treatment. We aimed to investigate biofluids pharmacokinetics of HSYA from XBJ to ensure the drug safety and to guide the clinical use. 2. A sensitive, rapid and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was applied to investigate pharmacokinetics of HSYA in TBI patients after intravenous administration of XBJ. Non-compartmental methods using DAS 3.0 software were applied to analyse the pharmacokinetic parameters. 3. A similar half-life (Plasmat1/2:14.55 ± 3.51 h vs. CSF t1/2:15.73 ± 3.63) was observed. HSYA reached the peak level rapidly, but exhibited a strongly slow absorption phase from blood to cerebrospinal fluid (CSF, PlasmaTmax: 0.69 ± 0.26 h vs. CSFTmax: 4.0 ± 2.62 h). HSYA exhibited much higher Cmax (PlasmaCmax: 9342.76 ± 2489.23 μg/L vs. CSFCmax: 98.08 ± 14.51 μg/L) and AUC0-t (PlasmaAUC0-t: 57490.5 ± 5560.3 μg h/L vs. CSFAUC0-t: 1851.6 ± 269.1 μg h/L), yet a shorter CL (PlasmaCL: 0.02 ± 0.002 L/h/kg vs. CSFCL: 0.55 ± 0.01 L/h/kg) in plasma than in CSF. The AUCCSF/AUCplasma of HSYA was almost 3.37%. 4. In Summary, the results demonstrate that part of HSYA come across blood-brain barrier after XBJ administration. This study provides evidence for better understanding the pharmacokinetics and potential for clinical guidance of XBJ for TBI treatment.Keywords
This publication has 23 references indexed in Scilit:
- UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injuryJournal of Ethnopharmacology, 2019
- Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of PhytochemicalsJournal of Neurotrauma, 2017
- Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2015
- Inflammation and Neuroprotection in Traumatic Brain InjuryJAMA Neurology, 2015
- Blood–brain barrier dysfunction following traumatic brain injuryMetabolic Brain Disease, 2015
- Trends in Visits for Traumatic Brain Injury to Emergency Departments in the United StatesJAMA, 2014
- Determination of hydroxysafflor yellow A in biological fluids of patients with traumatic brain injury by UPLC‐ESI‐MS/MS after injection of XuebijingBiomedical Chromatography, 2014
- Current pre-hospital traumatic brain injury management in ChinaWorld Journal of Emergency Medicine, 2014
- Elimination Rates of Dioxin Congeners in Former Chlorophenol Workers from Midland, MichiganEnvironmental Health Perspectives, 2013
- Changes in blood–brain barrier permeability to large and small molecules following traumatic brain injury in miceEuropean Journal of Neuroscience, 2007